Results 161 to 170 of about 19,271 (221)

The physiological impact of an N-terminal Halo-tag on glucose-dependent insulinotropic polypeptide receptor function in mice. [PDF]

Diabetes Obes Metab
Davies I, Manchanda Y, Sloop KW, Bloom SR, Tan TM, Tomas A, Jones B.   +6 more
europepmc   +1 more source

Worsening Postural Tachycardia Syndrome Is Associated With Increased Glucose-Dependent Insulinotropic Polypeptide Secretion. [PDF]

Hypertension, 2022
Breier NC, Paranjape SY, Scudder S, Mehr SE, Diedrich A, Flynn CR, Okamoto LE, Hartmann B, Gasbjerg LS, Shibao CA.   +9 more
europepmc   +1 more source

Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight. [PDF]

Mol Metab
Feetham CH, Ai M, Culotta I, Costa A, Hunter J, Brown RA, Coskun T, Emmerson PJ, D'Agostino G, Luckman SM.   +9 more
europepmc   +1 more source

Novel Use of Glucagon-Like Peptide-1 (GLP-1) and Dual Glucose-Dependent Insulinotropic Polypeptide (GIP)/GLP-1 Receptor Agonists in Maturity-Onset Diabetes of the Young (MODY). [PDF]

Cureus
Hilal A, Afandi B, Almazrouei R.
europepmc   +1 more source

Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease. [PDF]

Gut Microbes, 2023
Dong TS, Katzka W, Yang JC, Chang C, Arias-Jayo N, Lagishetty V, Balioukova A, Chen Y, Dutson E, Li Z, Mayer EA, Pisegna JR, Sanmiguel C, Jacobs JP.   +13 more
europepmc   +1 more source

The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Obstructive Sleep Apnea and Obesity. [PDF]

Curr Pulmonol Rep
Ellberg CC, Schwartz H, Witt A, McCowen KC, Fuentes AL, Malhotra A.   +5 more
europepmc   +1 more source

Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids. [PDF]

Diabetologia
Guccio N, Alcaino C, Miedzybrodzka EL, Santos-Hernández M, Smith CA, Davison A, Bany Bakar R, Kay RG, Reimann F, Gribble FM.   +9 more
europepmc   +1 more source

Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use. [PDF]

Cureus
Humaida S, Manzalji K, Seyam N, Al-Masalmani L.   +3 more
europepmc   +1 more source

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.

Endocr Rev
Wolfe MM, Boylan MO, Chin WW.
europepmc   +1 more source

A Case of Severe Cholestatic Hepatitis Induced by a Novel Dual Agonist of Glucagon-like Peptide-1 and Glucose-dependent Insulinotropic Polypeptide Receptors. [PDF]

J Clin Transl Hepatol
Jiang J, Shi M, Wu S, Cao M.
europepmc   +1 more source